Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.20
-0.12 (-1.06%)
Sep 8, 2026, 9:30 AM EDT - Market open
Keros Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $18 | Buy | Maintains | $18 | +60.71% | Sep 2, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $20 → $17 | Hold | Reiterates | $20 → $17 | +51.79% | Aug 11, 2026 |
| Wedbush | Wedbush | Hold Maintains $16 | Hold | Maintains | $16 | +42.86% | Aug 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +78.57% | Aug 4, 2026 |
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 4, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $30 → $23 | Buy | Maintains | $30 → $23 | +105.36% | Aug 4, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| Raymond James | Raymond James | Buy Maintains $23 → $20 | Buy | Maintains | $23 → $20 | +78.57% | Mar 5, 2026 |